Disparities in the delivery of #stroke care exist across Europe.π§
Earlier this year, we interviewed Diana Sousa to gain valuable insight into this.
Click here to watch the interview:
π buff.ly/iYi6Jew π
#Neuroscience #Neurology #EAN2025 #MedSky
At #EAN2025, Alberto De Lorenzo discussed how large language models, such as ChatGPT, will support clinicians in the diagnosis and management of polyneuropathy.
Watch here:
π₯ buff.ly/Apb7BGc
#Neuroscience #Neurology #MedSky
In an interview from #EAN2025, David Oliver comments on the complexities of assisted dying for patients with neurological diseases, highlighting the potential vulnerabilities of patients.
Watch here:
π buff.ly/Njqwqk9
#Neurology #Neuroscience #MedSky
π₯ Marcello Moccia comments on the association between neurofilament and invisible symptoms of #MultipleSclerosis, including cognitive dysfunction, depression, and fatigue:
π buff.ly/eW8A7YG π
#MS #MultScler #Neuroscience #Neurology #EAN2025 #MedSky
At #EAN2025, Ambra Stefani commented on the changes in #sleep and chronotype patterns that have evolved due to modern environmental pressures.π΄ π
Click here to find out more:
π₯ buff.ly/hpvVNKn
#Neuroscience #neurology #SleepResearch #MedSky
Do the EHF criteria for resistant and refractory #migraine reflect response to acute treatment?π€
Simona Sacco commented on this in an interview at #EAN2025:
π buff.ly/947dCPO π
#headache #Neuroscience #Neurology #MedSky
In neuromuscular disorders, there has been a shift toward targeted, disease-modifying therapies.π
Hear more about this in our interview with Massimiliano Filosto:
π buff.ly/BDGb8fS π
#Neurology #Neuroscience #EAN2025 #NMD #MovementDisorders
In an interview from #EAN2025, Marina Romozzi provides guidance on the selection of the most appropriate treatment for patients with #migraine.
Click here to watch:
π₯ buff.ly/R2YDmxA
#headache #Neuroscience #Neurology #MedSky
To find out about the 1.5-follow-up results from the EPSILON trial of opicapone in non-fluctuating #Parkinsons disease, watch our interview from #EAN2025 with Joaquim Ferreira by clicking here:
π₯ buff.ly/2H1tGN5
#Neurology #TrialUpdate #CTSM #Neuroscience #MedSky
In an interview from #EAN2025, Celia Oreja-Guevara discusses the importance of early detection of silent progression in patients with #MS.
Click here to watch:
π buff.ly/YhEAYwv π
#MultScler #MultipleSclerosis #Neurology #MedSky
The ERN EURO NMD Survey evaluated the most bothersome symptoms for patients with neuromuscular disorders.
What did the findings reveal?π€
Watch our interview with Michelangelo Mancuso to find out:
π₯ buff.ly/1xhLeZS
#EAN2025 #Neuroscience #Neurology
π₯ Watch our interview with BΓ‘rbara Guerra Leal to hear her share insights into a study using an in vitro model to understand microglial cell function in patients with #epilepsy:
π buff.ly/aMkveZQ π
#Neuroscience #Neurology #EAN2025
π₯ Angelo Antonini comments on the economic impact of reducing off-time and extending on-time in patients with #Parkinsons disease:
π buff.ly/XDh1FsN
#Neuroscience #Neurology #EAN2025 #MedSky
Want to gain valuable insight into the challenges of diagnosing idiopathic intracranial hypertension?
Watch our interview with Rigmor HΓΈjland Jensen from #EAN2025 here:
π buff.ly/igRsPbg
#Neuroscience #Neurology #Headache #MedSky
What does the future hold for the management of patients with neuromuscular disorders?π§
π₯ Hear from Massimiliano Filosto:
π buff.ly/YVAMDny π
#Neurology #Neuroscience #EAN2025
Why is the early involvement of palliative care in neurological diseases, such as #ALS, important?
David Oliver discusses this in an interview from #EAN2025:
π buff.ly/ADb06UF π
#MedSky #Neurology
Watch our interview with Marcello Moccia to hear about a study comparing different age-derived cut-offs for plasma neurofilament light chain in #MultipleSclerosis.
Click here:
π buff.ly/yaa0Q9L
#MS #MultScler #Neuroscience #Neurology #EAN2025
π₯ Messoud Ashina discusses a post-hoc analysis of the Phase IV PEARL study, which assessed the impact of the early initiation of fremanezumab as preventive treatment for #migraine:
π buff.ly/HPaZxzq π
#Neuroscience #Neurology #EAN2025 #CTSM #TrialUpdate #MedSky
π₯ Watch our recent interview with Diana de Sousa to hear about the goals and progress of the Stroke Action Plan for Europe.π§
Click here:
π buff.ly/XZc8qdq
#Stroke #Neuroscience #Neurology #EAN2025 #MedSky
Extreme temperatures are modifiers of neurological vulnerability in patients with #stroke & #epilepsy.π‘οΈπ§
In a recent interview, Anita Arsovska comments on the importance of incorporating temperature management into routine neurological care:
π₯ buff.ly/0YH1G98
#Neuroscience #Neurology #EAN2025
Want to hear about the OASIS study, a single-arm trial investigating the effects of opicapone on sleep disturbances in #Parkinsons disease?
Joaquim Ferreira shared the findings in an interview at #EAN2025:
π buff.ly/txQ4KDP π
#Neurology #TrialUpdate #CTSM #MedSky
How do you describe #ean2025 in Helsinki?
Thank you to everyone who made this congress a success.
We canβt wait to welcome you again at #ean2026 from 27-30 June!
π Stay tuned as we prepare for Geneva.
At #EAN2025, Michelangelo Mancuso discussed the potential benefits of elamipretide in treating primary mitochondrial myopathy of nuclear origin.
Click here to learn more:
π buff.ly/nf7eVK2 π
#Neuroscience #Neurology #MedSky
In a recent interview, Anastasia Bougea highlights the need for standardized protocols to study and diagnose alpha-synucleopathies.π§
Watch here:
π₯ buff.ly/4J317Gl
#Neuroscience #Neurology #EAN2025 #MovementDisorders #Parkinsons #MedSky
Hear about the predictors of response to treatment with subcutaneous foslevodopa/foscarbidopa infusions in #Parkinsons disease in an interview with Angelo Antonini:
π₯ buff.ly/8KbxgFp
#EAN2025 #Neuroscience #Neurology #MedSky
At #EAN2025, Gerard Maya presented a study investigating the prevalence of idiopathic REM sleep behavior disorder in the Spanish community.π΄ πͺπΈ
Watch the interview here:
π buff.ly/8fS4EfV π
#SleepResearch #Neuroscience #Neurology #MedSky
The exhibition hall at #ean2025 in Helsinki was full of energy, ideas, and innovation!
Hereβs a glimpse of some of the organisations who joined us to share their work and say hello π Thank you to all who were part of it.
Β
We look forward to seeing you again at #ean2026 in Geneva!
In an insightful interview from #EAN2025, Ambra Stefani shares insight into the updated guidelines for the diagnosis and treatment of restless legs syndrome.π¦΅
Click here to watch:
π₯ buff.ly/0XwcCSV
#Neuroscience #Neurology #MedSky
π₯ Gary Γlvarez Bravo discusses management strategies for hypokinetic and hyperkinetic #MovementDisorders encountered in emergency care:
π buff.ly/jhBM8av π
#Neuroscience #Neurology #EAN2025 #MedSky
It was fantastic to catch up with Diana Sousa after #EAN2025 to hear about an EAN/ESO joint session that took place at the meeting and to gain valuable insight into the latest developments in the field of #stroke.
Watch here:
π buff.ly/OlVvnuU
#Neuroscience #Neurology #MedSky